跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
畅沛 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Varenicline Tartrate Tablets
Approved
化学药品
Varenicline Tartrate Tablets
Pfizer Europe MA EEIG
🇨🇳 National Medical Products Administration
Approval Date
Aug 10, 2023
Approval ID
8TEMJeeFN5K
Company
Pfizer Europe MA EEIG
Type
化学药品
Approval Details
Approval Id
8TEMJeeFN5K
Approval Number
国药准字HJ20171222
Generic Name
酒石酸伐尼克兰片
Generic Name En
Varenicline Tartrate Tablets
Trade Name
畅沛
Drug Type
化学药品
Dosage Form
片剂
Strength
1.0mg
Reg Date
2023-08-10
Expired Date
2028-08-09
Company Name
Pfizer Europe MA EEIG
Production Company Name
R-Pharm Germany GmbH
Company Detail Path
/organization/pfizer-europe-ma-eeig
Production Company Detail Path
/organization/r-pharm-germany-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 10, 2023
Approval ID
8TEMJeeFN5K
Type
化学药品
Back to NMPA Approvals